Streetbeat News

Earnings

OMH

Ohmyhome reported significant growth in Q3 with a 51% year-over-year increase in brokerage gross transaction value, a 403% rise in renovation contracts, and a 23% increase in property management units.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:19 pm

FFNW

First Financial Northwest (NASDAQ:FFNW) reported a Q3 EPS loss of $(0.07), missing the $0.07 estimate, and sales of $8.45M, missing the $8.79M estimate. This represents a significant decrease from the previous year's earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:18 pm

SWK

Stanley Black & Decker reported mixed Q3 results with a revenue decline but improved margins due to cost savings. The company narrowed its 2024 EPS guidance, and shares fell 6.83% premarket.

Portfolio Pulse from Akanksha Bakshi

October 29, 2024 | 1:18 pm

TMDX

TransMedics Group, Inc. (NASDAQ:TMDX) reported weaker-than-expected quarterly earnings and sales, leading analysts to cut their price targets. Despite the disappointing results, the company remains optimistic about its growth prospects. Analysts from Needham, Baird, and Canaccord Genuity lowered their price targets but maintained positive ratings on the stock.

Portfolio Pulse from Avi Kapoor

October 29, 2024 | 1:15 pm

CX

Cemex reported disappointing Q3 results, missing both earnings and sales estimates. Analysts have responded by downgrading the stock and lowering price targets, leading to an 8.7% drop in share price.

Portfolio Pulse from Avi Kapoor

October 29, 2024 | 1:06 pm

BP

DFRA

BP's Q3 results show a revenue miss, production decline, and rising debt, leading to a drop in stock price. Despite some positive aspects like beating EPS expectations and ongoing share buybacks, the outlook remains cautious with expected lower production and refining margins.

Portfolio Pulse from Lekha Gupta

October 29, 2024 | 1:04 pm

HTLD

Heartland Express reported a Q3 2024 GAAP EPS of $(0.12), missing the $0.01 estimate by a significant margin. Sales were $259.861M, also missing the $268.440M estimate and showing a 11.92% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 1:03 pm

TGTX

Analysts have varied opinions on TG Therapeutics (NASDAQ:TGTX), with most being bullish. The average 12-month price target has increased to $40.4. The company has shown strong financial performance with significant revenue growth and high net margins, but faces challenges with debt management.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 1:00 pm

CDNS

Cadence Design Systems (NASDAQ:CDNS) reported better-than-expected Q3 results, with earnings and sales surpassing analyst estimates. Despite this, shares fell 1.8%. Analysts revised their price targets, with Needham lowering to $315 and Baird raising to $340.

Portfolio Pulse from Avi Kapoor

October 29, 2024 | 12:57 pm

AMKR

CHKP

CROX

CVI

DHI

DQ

HLIT

JBI

TMDX

XRX

Several major stocks, including TransMedics Group, CVR Energy, Xerox, Harmonic, Amkor Technology, Janus International, Crocs, Daqo New Energy, D.R. Horton, and Check Point Software, experienced significant declines in pre-market trading due to weak quarterly results and other financial disappointments.

Portfolio Pulse from Avi Kapoor

October 29, 2024 | 12:52 pm